
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $101.6M | -- | -- | $1.52 | -- |
08/05/2025 | Q2 | $92M | -- | -- | $1.40 | -- |
05/06/2025 | Q1 | $96.2M | $88.2M | $1.20 | $1.52 | -$0.32 |
02/19/2025 | Q4 | $91.4M | $91.1M | $1.52 | $1.85 | -$0.33 |
11/04/2024 | Q3 | $83.1M | $83.8M | $0.91 | $1.33 | -$0.42 |
08/05/2024 | Q2 | $65.5M | $70.3M | $0.53 | $0.99 | -$0.46 |
05/06/2024 | Q1 | $47.4M | $45.3M | $0.03 | $0.29 | -$0.26 |
02/26/2024 | Q4 | $29.9M | $42.1M | $0.31 | -$0.25 | $0.56 |
11/06/2023 | Q3 | -- | -- | $2.79 | -$0.67 | $3.46 |
08/07/2023 | Q2 | -- | -- | -$1.25 | -$0.74 | -$0.51 |
05/08/2023 | Q1 | -- | -- | -$1.76 | -$1.37 | -$0.39 |
02/27/2023 | Q4 | -- | -- | -$1.25 | -$0.56 | -$0.69 |
11/07/2022 | Q3 | -- | -- | -$1.17 | -$1.26 | $0.09 |
08/08/2022 | Q2 | -- | -- | -$1.10 | -$1.00 | -$0.10 |
05/09/2022 | Q1 | -- | -- | -$1.99 | -$1.06 | -$0.93 |
02/28/2022 | Q4 | -- | -- | -$0.95 | -$0.73 | -$0.22 |
11/08/2021 | Q3 | -- | -- | -$0.70 | -$0.74 | $0.04 |
08/09/2021 | Q2 | -- | -- | -$0.74 | -$0.78 | $0.04 |
05/10/2021 | Q1 | -- | -- | -$0.74 | -$0.56 | -$0.18 |
03/01/2021 | Q4 | -- | -- | -$0.53 | -$0.59 | $0.06 |
11/09/2020 | Q3 | -- | -- | -$0.49 | -$0.46 | -$0.03 |
08/10/2020 | Q2 | -- | -- | -$0.37 | -$0.39 | $0.02 |
05/04/2020 | Q1 | -- | -- | -$0.31 | -$0.40 | $0.09 |
03/10/2020 | Q4 | -- | -- | -$0.31 | -$0.33 | $0.02 |
11/04/2019 | Q3 | -- | -- | -$0.25 | -$0.40 | $0.15 |
08/05/2019 | Q2 | -- | -- | -$0.37 | -$0.31 | -$0.06 |
05/06/2019 | Q1 | -- | -- | -$0.29 | -- | -- |
12/31/2018 | Q4 | -- | -- | -$0.28 | -- | -- |
11/05/2018 | Q3 | -- | -- | -$0.26 | -- | -- |
08/06/2018 | Q2 | -- | -- | -$0.22 | -- | -- |
05/07/2018 | Q1 | -- | -- | -$0.21 | -- | -- |
12/31/2017 | Q4 | -- | -- | -$0.14 | -- | -- |
11/13/2017 | Q3 | -- | -- | -$1.26 | -- | -- |
06/30/2017 | Q2 | -- | -- | -$0.09 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$0.12 | -- | -- |
12/31/2016 | Q4 | -- | -- | -$0.15 | -- | -- |
09/30/2016 | Q3 | -- | -- | -$0.08 | -- | -- |
Krystal Biotech reported $88.2M worth of top line sales in its most recent quarter.
Krystal Biotech announced earnings per share of $1.20 which represents a miss of analyst forecast a $1.52 per share.
Krystal Biotech reported $83.2M that represents $2.78 per share over the last quarter.
Krystal Biotech's earnings are forecast to grow from $3.00 per share to $5.17 per share next year representing an increase of 109.35%.
Krystal Biotech's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.